These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
275 related articles for article (PubMed ID: 22247700)
21. Dissecting and targeting the growth factor-dependent and growth factor-independent extracellular signal-regulated kinase pathway in human schwannoma. Ammoun S; Flaiz C; Ristic N; Schuldt J; Hanemann CO Cancer Res; 2008 Jul; 68(13):5236-45. PubMed ID: 18593924 [TBL] [Abstract][Full Text] [Related]
22. Cadmium induces Wnt signaling to upregulate proliferation and survival genes in sub-confluent kidney proximal tubule cells. Chakraborty PK; Lee WK; Molitor M; Wolff NA; Thévenod F Mol Cancer; 2010 May; 9():102. PubMed ID: 20459685 [TBL] [Abstract][Full Text] [Related]
23. Insulin-like growth factor-binding protein-1 (IGFBP-1) regulates human schwannoma proliferation, adhesion and survival. Ammoun S; Schmid MC; Zhou L; Ristic N; Ercolano E; Hilton DA; Perks CM; Hanemann CO Oncogene; 2012 Mar; 31(13):1710-22. PubMed ID: 21892205 [TBL] [Abstract][Full Text] [Related]
24. P-21-activated protein kinase-1 functions as a linker between insulin and Wnt signaling pathways in the intestine. Sun J; Khalid S; Rozakis-Adcock M; Fantus IG; Jin T Oncogene; 2009 Sep; 28(35):3132-44. PubMed ID: 19581924 [TBL] [Abstract][Full Text] [Related]
25. A Rac1/PAK1 cascade controls β-catenin activation in colon cancer cells. Zhu G; Wang Y; Huang B; Liang J; Ding Y; Xu A; Wu W Oncogene; 2012 Feb; 31(8):1001-12. PubMed ID: 21822311 [TBL] [Abstract][Full Text] [Related]
26. Downregulated microRNA-200a in meningiomas promotes tumor growth by reducing E-cadherin and activating the Wnt/beta-catenin signaling pathway. Saydam O; Shen Y; Würdinger T; Senol O; Boke E; James MF; Tannous BA; Stemmer-Rachamimov AO; Yi M; Stephens RM; Fraefel C; Gusella JF; Krichevsky AM; Breakefield XO Mol Cell Biol; 2009 Nov; 29(21):5923-40. PubMed ID: 19703993 [TBL] [Abstract][Full Text] [Related]
27. Merlin/NF2 regulates angiogenesis in schwannomas through a Rac1/semaphorin 3F-dependent mechanism. Wong HK; Shimizu A; Kirkpatrick ND; Garkavtsev I; Chan AW; di Tomaso E; Klagsbrun M; Jain RK Neoplasia; 2012 Feb; 14(2):84-94. PubMed ID: 22431917 [TBL] [Abstract][Full Text] [Related]
28. The neurofibromatosis 2 protein, merlin, regulates glial cell growth in an ErbB2- and Src-dependent manner. Houshmandi SS; Emnett RJ; Giovannini M; Gutmann DH Mol Cell Biol; 2009 Mar; 29(6):1472-86. PubMed ID: 19103750 [TBL] [Abstract][Full Text] [Related]
29. Cellular prion protein (PrP Provenzano L; Ryan Y; Hilton DA; Lyons-Rimmer J; Dave F; Maze EA; Adams CL; Rigby-Jones R; Ammoun S; Hanemann CO Oncogene; 2017 Nov; 36(44):6132-6142. PubMed ID: 28692055 [TBL] [Abstract][Full Text] [Related]
30. PAK1 inhibition reduces tumor size and extends the lifespan of mice in a genetically engineered mouse model of Neurofibromatosis Type 2 (NF2). Hawley E; Gehlhausen J; Karchugina S; Chow HY; Araiza-Olivera D; Radu M; Smith A; Burks C; Jiang L; Li X; Bessler W; Masters A; Edwards D; Burgin C; Jones D; Yates C; Clapp DW; Chernoff J; Park SJ Hum Mol Genet; 2021 Aug; 30(17):1607-1617. PubMed ID: 34075397 [TBL] [Abstract][Full Text] [Related]
31. Tissue transglutaminase regulates β-catenin signaling through a c-Src-dependent mechanism. Condello S; Cao L; Matei D FASEB J; 2013 Aug; 27(8):3100-12. PubMed ID: 23640056 [TBL] [Abstract][Full Text] [Related]
32. Global Proteome and Phospho-proteome Analysis of Merlin-deficient Meningioma and Schwannoma Identifies PDLIM2 as a Novel Therapeutic Target. Bassiri K; Ferluga S; Sharma V; Syed N; Adams CL; Lasonder E; Hanemann CO EBioMedicine; 2017 Feb; 16():76-86. PubMed ID: 28126595 [TBL] [Abstract][Full Text] [Related]
33. Regulation of mTOR complex 2 signaling in neurofibromatosis 2-deficient target cell types. James MF; Stivison E; Beauchamp R; Han S; Li H; Wallace MR; Gusella JF; Stemmer-Rachamimov AO; Ramesh V Mol Cancer Res; 2012 May; 10(5):649-59. PubMed ID: 22426462 [TBL] [Abstract][Full Text] [Related]
34. The NF2 tumor suppressor regulates microtubule-based vesicle trafficking via a novel Rac, MLK and p38(SAPK) pathway. Hennigan RF; Moon CA; Parysek LM; Monk KR; Morfini G; Berth S; Brady S; Ratner N Oncogene; 2013 Feb; 32(9):1135-43. PubMed ID: 22525268 [TBL] [Abstract][Full Text] [Related]
35. Overexpression of the NF2 gene inhibits schwannoma cell proliferation through promoting PDGFR degradation. Fraenzer JT; Pan H; Minimo L; Smith GM; Knauer D; Hung G Int J Oncol; 2003 Dec; 23(6):1493-500. PubMed ID: 14612918 [TBL] [Abstract][Full Text] [Related]
37. Dysregulation of Wnt/β-catenin signaling by protein kinases in hepatocellular carcinoma and its therapeutic application. Li Q; Sun M; Wang M; Feng M; Yang F; Li L; Zhao J; Chang C; Dong H; Xie T; Chen J Cancer Sci; 2021 May; 112(5):1695-1706. PubMed ID: 33605517 [TBL] [Abstract][Full Text] [Related]
38. Regulation of Sertoli-germ cell adherens junction dynamics via changes in protein-protein interactions of the N-cadherin-beta-catenin protein complex which are possibly mediated by c-Src and myotubularin-related protein 2: an in vivo study using an androgen suppression model. Zhang J; Wong CH; Xia W; Mruk DD; Lee NP; Lee WM; Cheng CY Endocrinology; 2005 Mar; 146(3):1268-84. PubMed ID: 15591133 [TBL] [Abstract][Full Text] [Related]
39. Inactivation of the NF2 tumor suppressor protein merlin in DU145 prostate cancer cells. Horiguchi A; Zheng R; Shen R; Nanus DM Prostate; 2008 Jun; 68(9):975-84. PubMed ID: 18361411 [TBL] [Abstract][Full Text] [Related]
40. Loss of SOX10 function contributes to the phenotype of human Merlin-null schwannoma cells. Doddrell RD; Dun XP; Shivane A; Feltri ML; Wrabetz L; Wegner M; Sock E; Hanemann CO; Parkinson DB Brain; 2013 Feb; 136(Pt 2):549-63. PubMed ID: 23413263 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]